Evidence map›Paper›PMID 41309561›Full record

ArticleCell death & disease2025

Retraction Note: Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.

Ting Xiao, Weilong Zhong, Jianmin Zhao, Baoxin Qian, Huijuan Liu, Shuang Chen, Kailiang Qiao, Yueyang Lei, Shumin Zong, Hongzhi Wang and 7 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Ting Xiao *High-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Weilong Zhong *High-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Jianmin Zhao *Pathology Department, Shun Yi District Hospital, 101300, Beijing, China.
Baoxin Qian *Department of Gastroenterology and Hepatology, Tianjin Key Laboratory of Artificial Cells, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, 300170, Tianjin, China.
Huijuan LiuHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Shuang ChenHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Kailiang QiaoHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Yueyang LeiHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Shumin ZongHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Hongzhi WangHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Yuan LiangHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Heng ZhangState Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, 300000, Tianjin, China.
Jing MengHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Honggang ZhouHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China.
Tao SunHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China. sunrockmia@hotmail.com.
Yanrong LiuHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China. liuyanrong1984@163.com.
Cheng YangHigh-throughput Molecular Drug Screening Centre, Tianjin International Joint Academy of Biomedicine, 300070, Tianjin, China. cheng.yang@nankai.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41309561
PMCPMC12660827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.